Exosomes: a clinician's guide

Exosomes are tiny, cell-derived vesicles — nanoscale “message carriers” that shuttle growth factors, proteins, lipids and genetic signals between cells to prompt repair and renewal. In UK aesthetic practice the crucial nuance is how they may be used: exosomes are not licensed as injectable medicines, so the compliant application is topical — applied to freshly treated skin after microneedling, lasers or energy-based devices to support recovery and skin quality. Used this way they are one of the most talked-about regenerative options in clinic — and one of the most important to understand properly.

What exactly are exosomes?

Exosomes are a type of extracellular vesicle, typically around 30–150 nanometres across, released naturally by cells. They carry a “cargo” of proteins, growth factors, lipids and genetic material (such as mRNA and microRNA) that can influence the behaviour of the cells that take them up. In effect, they are the body's own signalling parcels.

In aesthetics, the exosomes used are derived from a range of sources — human mesenchymal stem cell (MSC) lines (the most studied but also the most tightly regulated and debated), and non-human sources used in skincare such as plant-derived, milk-derived and other cultured exosomes. Product quality varies enormously depending on the source, how the exosomes are purified, and how well they are characterised. For more, see where do exosomes come from.

How do exosomes work?

Exosomes work through cell-to-cell signalling. When taken up by recipient cells, their cargo can modulate fibroblast activity, dampen inflammation, and support angiogenesis and tissue repair. That signalling role is the rationale for using them to enhance skin recovery and quality — particularly after a controlled skin injury, when the skin is primed to respond.

What are exosomes used for in aesthetics?

In UK practice, exosomes are used predominantly as a topical adjunct, applied immediately after skin-barrier-disrupting treatments — microneedling, fractional or resurfacing lasers, and radiofrequency microneedling — when absorption is highest. The aim is to support downtime, calm redness and improve overall skin quality. They are also used for scalp and hair support. They are not a licensed standalone injectable treatment in the UK.

• Post-procedure recovery — applied after microneedling / energy devices to support healing and results.
• Skin quality — tone, texture, radiance and redness.
• Scalp & hair — supportive care (e.g. the DE|RIVE range).

Are exosomes legal — and how should they be used?

This is the point every clinician needs to be clear on. In the UK, exosomes are not licensed as injectable medicines, and injecting them falls outside approved use — a position that has prompted patient-safety warnings from bodies such as Save Face.³ The accepted, compliant route is topical application by a trained professional, with honest consent about what the product is and how strong (or otherwise) the evidence is. Sourcing, purity and manufacturer transparency matter a great deal.

How do exosomes differ from polynucleotides and PRP?

These regenerative options are often confused:

• Exosomes — cell-signalling vesicles, used topically in UK aesthetic practice.
• Polynucleotides — purified DNA fragments, injected, that biostimulate the skin. See our polynucleotides guide.
• PRP — platelet-rich plasma prepared from the patient's own blood, then injected.

For a fuller side-by-side, read exosomes vs polynucleotides vs PRP.

What does the evidence say?

The evidence is emerging and promising, particularly for exosomes as a post-procedure adjunct and in hair. Reviews and early studies report improvements in skin quality, redness and recovery.¹ However, high-quality human randomised trials remain limited, products are heterogeneous and poorly standardised, and there are genuine regulatory, quality and safety questions still to resolve.² The honest position with patients is that exosomes are an exciting, fast-moving area with real potential — but not a proven, standardised or licensed injectable treatment.

How are exosomes used in a treatment?

In a typical protocol, exosomes are applied topically straight after a controlled skin treatment such as microneedling or laser, while the skin's barrier is transiently open and uptake is greatest. They are often paired with supporting pre- and post-treatment serums and may be used as a short course. Rather than adding downtime, the goal is to support and shorten it.

Safety and patient selection

Used topically, exosome products are generally well tolerated. The most important safety issues are not about the topical serum itself but about unlicensed injectable use, product sourcing and contamination risk, and overclaiming. Contraindications largely follow the procedure the exosomes are paired with (for example, active skin infection or inflammation). Thorough, honest consent is essential given the regulatory position.

How to choose a clinician-grade exosome product

When selecting an exosome system, scrutinise the source (what the exosomes are derived from), the purification and characterisation data, regulatory status, the strength of the evidence, and the clinical support and training behind the brand. Our own research into how UK clinicians choose products found that clinical results, safety and regulatory approval consistently outrank price and marketing — a sensible lens for a category this new. Read more on our original research page.

At Harley Supplies we supply the EXO|E and DE|RIVE ranges — topical exosome systems developed for skin and hair. Swipe through the full range:

DE|RIVE Daily Hair Support Leave In ConditionerDE|RIVE Daily Hair Support ShampooDE|RIVE Hair Regenerative Master Case - Package of 10 KitsDE|RIVE Hair SerumD|TOX – Pre-Treatment Skincare SerumEXO|E - 10 Pack SyringeEXO|E - Exosome Skincare System - 3 Treatment KitEXO|E - Exosome Skincare System - Master Case (10 syringes + 10 x 30ml D|TOX / 10 x 30ml RE|PAIR)RE|PAIR – Post-Treatment Skincare Serum

Frequently asked questions

This guide is intended for registered healthcare professionals. It summarises current evidence for educational purposes and is not a substitute for the product SPC/IFU, manufacturer training, or your own clinical judgement. Regulatory positions on exosomes are evolving — verify the current status before use.

Written by

Dr Emmaline Ashley

Aesthetic Doctor · GMC 7582958 · COO of Harley Supplies

Dr Emmaline Ashley is an aesthetic doctor and published researcher in aesthetic medicine, with peer-reviewed work spanning product safety, regenerative treatments and medical education. She is a member of the Acquisition Aesthetics clinical faculty.

Our researchResearchGateLinkedIn